Author

Ana Maria Meireles

Observed names: Ana M Meireles, Ana M. Meireles

Institutions: IPO Porto, Centro de Investigação do Instituto Português de Oncologia do Porto Francisco Gentil, RISE - Health Research Network

Observed institutions: IPO Porto, Centro de Investigação do Instituto Português de Oncologia do Porto Francisco Gentil, RISE - Health Research Network

ORCID: 0000-0002-6465-1174

Observed ORCID: 0000-0002-6465-1174

OpenAlex ID: A5102548220

NEWS, NEWS2, and qSOFA accuracy in predicting sepsis-related mortality in acute myeloid leukemia: a retrospective single-center analysis

2024 · Ana M. Meireles, Leonardo M. Moço, et al. · Porto Biomedical Journal · 4

Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study

2025 · Ana Maria Meireles, Rita Calisto, et al. · Hematology Transfusion and Cell Therapy · 2

Hemophagocytic lymphohistiocytosis in a patient with Epstein–Barr virus-positive diffuse large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy

2024 · Ana Maria Meireles, Gloria Iacoboni, et al. · Immunotherapy · 2

COVID-19-Associated Cognitive Biases on Pneumonia Differential Diagnosis

2024 · Pedro Cruz, Ana M Meireles, et al. · Cureus · 1

Pb2576: News, News2 and Qsofa Accuracy to Predict Sepsis-related Mortality in Acute Myeloid Leukemia: a Retrospective Single-centre Analysis

2023 · Ana Maria Meireles, Leonardo Moço, et al. · HemaSphere · 1

Effects of fludarabine dosage on transplant-related outcomes in hematopoietic stem cell transplantation

2025 · Ana Maria Meireles, Ana Carolina Dominguesde Oliveira Rodrigues Amarante, et al. · Leukemia & lymphoma/Leukemia and lymphoma

Análise Factorial Aplicada à Ciência Regional

2011 · João Oliveira Soares, Ana Maria Meireles · Dialnet (Universidad de la Rioja)

Works count: 7

Citation count: 10

H-index: 2

I10-index: